AIM
PFE icon

Anchor Investment Management’s Pfizer PFE Stock Holding History

Anchor Investment Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,000
Closed -$26.5K – 1050
2024
Q4 		$26.5K Hold
1,000
– – ﹤0.01% 667
2024
Q3 		$28.9K Hold
1,000
– – ﹤0.01% 647
2024
Q2 		$28K Buy
+1,000
New +$27.5K ﹤0.01% 595

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Anchor Investment Management's PFE Position: Q1 2026 in Review

Anchor Investment Management reduced its Pfizer (PFE) stake by 3% in Q1 2026, selling an estimated $71K and leaving 87,568 shares worth $2.46M. The position accounts for 0.21% of the portfolio, ranked #123.

Anchor Investment Management first reported a position in PFE in Q1 2016 and has held it in 41 quarters since. The position peaked at $9.36M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Anchor Investment Management held 87,568 shares of Pfizer worth $2.46M as of Q1 2026.
  • Anchor Investment Management sold 2,667 Pfizer shares in Q1 2026, an estimated $71K.
  • Pfizer made up 0.21% of Anchor Investment Management's portfolio in Q1 2026, its #123 holding.
  • Anchor Investment Management first reported a position in Pfizer in Q1 2016 and has held it in 41 quarters since.
  • Anchor Investment Management's Pfizer position peaked at $9.36M in Q4 2021.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Anchor Investment Management's 13F filing for Q1 2026, filed 1 May 2026.